相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Research progress in the relationship between type 2 diabetes mellitus and intestinal flora
Quantao Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice
Marta Olivares et al.
DIABETOLOGIA (2018)
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
Liping Zhao et al.
SCIENCE (2018)
Glycemic excursions are positively associated with HbA1c reduction from baseline after treatment with acarbose in patients with type 2 diabetes on metformin monotherapy
Jun-Sing Wang et al.
JOURNAL OF DIABETES (2017)
Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
Muhammad U. Sohail et al.
JOURNAL OF DIABETES RESEARCH (2017)
Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective
Francesco Zaccardi et al.
POSTGRADUATE MEDICAL JOURNAL (2016)
Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels
Jin-Ping Zhang et al.
JOURNAL OF DIABETES (2016)
Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis
F. Zaccardi et al.
DIABETES OBESITY & METABOLISM (2016)
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial
Peter Gde et al.
DIABETOLOGIA (2016)
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
Alexandra Kautzky-Willer et al.
ENDOCRINE REVIEWS (2016)
Rectocutaneous fistula with transmigration of the suture: a rare delayed complication of vault fixation with the sacrospinous ligament (vol 27, pg 155, 2016)
Pratima Datta Kadam et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2016)
Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose
Ganiyu Oboh et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2016)
Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo
Hong Yang et al.
ONCOTARGET (2016)
Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study
Manuj Sharma et al.
BMJ OPEN (2016)
Structural modulation of the gut microbiota and the relationship with body weight: compared evaluation of liraglutide and saxagliptin treatment
Lin Wang et al.
SCIENTIFIC REPORTS (2016)
Analysis of the add-on effect of -glucosidase inhibitor, acarbose in insulin therapy: A pilot study
Feng-Fei Li et al.
BIOMEDICAL REPORTS (2016)
Gut microorganisms as promising targets for the management of type 2 diabetes
Nathalie M. Delzenne et al.
DIABETOLOGIA (2015)
microRNA-184 functions as tumor suppressor in renal cell carcinoma
Zhengming Su et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences
Laura M. Cox et al.
CELL (2014)
Saxagliptin improves glycemic control by modulating postprandial glucagon and C-peptide levels in Chinese patients with type 2 diabetes
Mikaela Sjostrand et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Vildagliptin more effectively achieves a composite endpoint of HbA1c < 7.0% without hypoglycaemia and weight gain compared with glimepiride after 2 years of treatment
Giovanni Bader et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2013)
Octreotide improves early dumping syndrome potentially through incretins: a case report
Daisuke Sato et al.
ENDOCRINE JOURNAL (2013)
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Magnus Simren et al.
GUT (2013)
Clinically relevant reductions in HbA1c without hypoglycaemia: results across four studies of saxagliptin
C. S. Karyekar et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2013)
Gut metagenome in European women with normal, impaired and diabetic glucose control
Fredrik H. Karlsson et al.
NATURE (2013)
The gut microbiota and obesity: from correlation to causality
Liping Zhao
NATURE REVIEWS MICROBIOLOGY (2013)
Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents
Kenneth C. Copeland et al.
PEDIATRICS (2013)
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment
Valentina Lukashevich et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2013)
Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
C. Pan et al.
DIABETES OBESITY & METABOLISM (2012)
Vildagliptin Added to Metformin on β-Cell Function After a Euglycemic Hyperinsulinemic and Hyperglycemic Clamp in Type 2 Diabetes Patients
Giuseppe Derosa et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2012)
Pharmacodynamic comparison of two formulations of Acarbose 100-mg tablets
S. Lee et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
A metagenome-wide association study of gut microbiota in type 2 diabetes
Junjie Qin et al.
NATURE (2012)
Type 2 diabetes after gastric bypass: remission in five models using HbA1c, fasting blood glucose, and medication status
Robin Blackstone et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2012)
Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes
R. R. Henry et al.
DIABETES OBESITY & METABOLISM (2011)
Nateglinide and acarbose for postprandial glucose control after optimizing fasting glucose with insulin glargine in patients with type 2 diabetes
Mi K. Kim et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
International noninterventional study of acarbose treatment in patients with type 2 diabetes mellitus
Chunlin Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging
M. A. Dabbah et al.
MEDICAL IMAGE ANALYSIS (2011)
Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
Hiroyasu Uzui et al.
JOURNAL OF DIABETES INVESTIGATION (2011)
Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies
Anja Schweizer et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
Beneficial effect of xylo-oligosaccharides and fructo-oligosaccharides in streptozotocin-induced diabetic rats
Duraiswamy Gobinath et al.
BRITISH JOURNAL OF NUTRITION (2010)
Vildagliptin A Review of its Use in Type 2 Diabetes Mellitus
Gillian M. Keating
DRUGS (2010)
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice
Chenhong Zhang et al.
ISME JOURNAL (2010)
Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
Zhanguo Gao et al.
DIABETES (2009)
Butyricimonas synergistica gen. nov., sp nov and Butyricimonas virosa sp nov., butyric acid-producing bacteria in the family 'Porphyromonadaceae' isolated from rat faeces
Mitsuo Sakamoto et al.
INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY (2009)
Treatment with the Dipeptidyl Peptidase-4 Inhibitor Vildagliptin Improves Fasting Islet-Cell Function in Subjects with Type 2 Diabetes
David A. D'Alessio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A core gut microbiome in obese and lean twins
Peter J. Turnbaugh et al.
NATURE (2009)
SIRT1 Knockout Leads to Angiogenesis Deficiency in Adipose Tissue through Macrophage Dysfunction
Fen Xu et al.
DIABETES (2009)
An obesity-associated gut microbiome with increased capacity for energy harvest
Peter J. Turnbaugh et al.
NATURE (2006)
Characterization of maltose and maltotriose transport in the acarbose-producing bacterium Actinoplanes sp.
C Brunkhorst et al.
RESEARCH IN MICROBIOLOGY (2005)
分享论文
